1. Introduction {#sec1}
===============

Hydrogen sulfide (H~2~S) has been increasingly recognized as a key signaling molecule in human (patho)physiology. While being able to regulate cell redox homeostasis and other crucial physiological functions at low (nM) concentrations \[[@B1]--[@B4]\], at higher (*μ*M) levels, H~2~S exerts toxicity both inhibiting O~2~ consumption by cytochrome *c* oxidase (CcOX) in the mitochondrial electron transport chain \[[@B5]\] and impairing O~2~ transport/storage through covalent modification of the heme porphyrin ring in globins (reviewed in \[[@B6]\]). It is therefore crucial that cells tightly control H~2~S bioavailability to prevent toxicity.

In humans, at least three enzymes are directly involved in H~2~S synthesis (reviewed in \[[@B1], [@B7], [@B8]\]): cystathionine *β*-synthase (CBS) and cystathionine *γ*-lyase (CSE), belonging to the transulfuration pathway, and 3-mercaptopyruvate sulfurtransferase (MST). Of these, CBS is inhibited with relatively high affinity by nitric oxide (NO) and carbon monoxide (CO), particularly in the presence of the allosteric stimulator [S]{.smallcaps}-adenosyl-[L]{.smallcaps}-methionine \[[@B9]--[@B13]\]. H~2~S breakdown is instead mostly accomplished by a mitochondrial enzymatic pathway that couples the oxidation of H~2~S into thiosulfate (S~2~O~3~^2-^) and sulfate (SO~4~^2-^) to ATP synthesis \[[@B14]\]. The first step of sulfide breakdown is catalyzed by the membrane-associated sulfide:quinone oxidoreductase (SQR). This flavoprotein transfers electrons from H~2~S to coenzyme Q in the mitochondrial electron transfer chain, thus making H~2~S the first inorganic substrate that is able to sustain mitochondrial respiration \[[@B15]\]. Concomitantly, SQR transfers the H~2~S sulfur atom to an acceptor, leading to the formation of glutathione persulfide (GSSH) \[[@B16], [@B17]\] or, less likely, S~2~O~3~^2-^ \[[@B18], [@B19]\]. Differences in the SQR substrate specificity were recently reported comparing the soluble with the nanodisc-incorporated enzyme \[[@B20]\]. Three additional enzymes, persulfide dioxygenase (ETHE1), thiosulfate sulfurtransferase, and sulfite oxidase, cooperate with SQR in the mitochondrial sulfide oxidation pathway, to oxidize H~2~S into SO~4~^2-^ and S~2~O~3~^2-^. To process 1 H~2~S molecule, mitochondria overall consume \~0.75 O~2~ molecules (0.25 by CcOX plus 0.5 by ETHE1, \[[@B21]\]). Besides being metabolized through the mitochondrial sulfide-oxidizing pathway, H~2~S can be oxidized by several metalloproteins such as globins, heme-based sensors of diatomic gaseous molecules, catalase, and peroxidases (see \[[@B8]\] and references therein) or be catabolized by the cytosolic thiol methyltransferase \[[@B22]\].

*In vivo*, H~2~S can therefore exert a dual effect on cell bioenergetics, at lower concentrations stimulating *via* SQR mitochondrial respiration and thus ATP synthesis or causing a reversible inhibition of CcOX at higher concentrations (reviewed in \[[@B23]--[@B26]\]). Notably, the sulfide-oxidizing activity varies considerably between different cell types and tissues, spanning from undetectable, as e.g., in neuroblastoma cells, to high, as observed in colonocytes \[[@B15], [@B21], [@B27]\]. The high H~2~S-detoxifying ability of colonocytes is perhaps not surprising as these cells are physiologically exposed to the fairly high H~2~S levels produced by the gut microbiota (reviewed in \[[@B28]\]).

Among other diseases, cancer has been increasingly associated with alterations of H~2~S metabolism \[[@B29]--[@B31]\]. In particular, CBS has been shown to be overexpressed in cell lines and samples of colorectal cancer \[[@B32]\] and other cancer types \[[@B33]--[@B36]\]. In colorectal cancer cell lines, CBS-derived H~2~S was proposed to promote cell proliferation and angiogenesis and to sustain cellular bioenergetics by stimulating both oxidative phosphorylation and glycolytic ATP synthesis. The enzyme is therefore currently recognized as a drug target \[[@B29], [@B31], [@B37]\]. CSE and CSE-derived H~2~S have been recognized as key elements in melanoma progression \[[@B38]\]. All three H~2~S-synthesizing enzymes have been posited to contribute to the correlation between increased H~2~S production and tumor stage and grade in bladder urothelial cell carcinoma \[[@B39]\]. Moreover, Szczesny et al. \[[@B36]\] observed higher expression levels of all three H~2~S-generating enzymes and increased H~2~S-producing activity in lung adenocarcinoma samples as compared to the adjacent normal lung tissue. A link between H~2~S production and mitochondrial DNA repair was proposed, and the inhibition of CBS and CSE by aminooxyacetic acid or siRNA-mediated depletion of CBS, CSE, or MST in the lung adenocarcinoma A549 cell line resulted in compromised integrity of mitochondrial DNA. Irrespectively of the downstream mechanisms linking increased H~2~S levels and cell proliferation and/or tumor progression, it remains to be established how cancer cells circumvent the potentially toxic effects of increased H~2~S.

Hypoxia is a common factor in the microenvironment of solid tumors that has been recognized to be associated to drug resistance and promotion of cancer progression, metastasization, and angiogenesis (see \[[@B40]\] for a review). The effect of hypoxia on cancer metabolism has been extensively investigated (reviewed in \[[@B41]--[@B43]\]). Among other changes, hypoxic cells undergo a reduction in mitochondrial mass, resulting from reduced biogenesis of this organelle and enhanced mitophagy \[[@B44]--[@B46]\]. Because mitochondria are the main site of sulfide oxidation, in the absence of compensatory mechanisms, hypoxic cells are expected to display a reduced ability to detoxify sulfide. The intricate interplay between H~2~S and O~2~ has been extensively investigated (reviewed in \[[@B47], [@B48]\]). As O~2~ facilitates both the chemical and enzymatic oxidative decomposition of H~2~S into persulfides and polysulfides, at low O~2~ tension a higher stability of H~2~S is expected. Furthermore, hypoxic/ischemic conditions have been reported to enhance H~2~S synthesis, through upregulation or stimulation of the sulfide-synthesizing enzymes \[[@B49], [@B50]\], accumulation of CBS in mitochondria, likely augmenting the H~2~S mitochondrial levels \[[@B51]\], and release of CO-mediated inhibition of CBS and CSE \[[@B52], [@B53]\]. Hypoxia is thus expected to increase H~2~S bioavailability, a condition that can have opposite physiological consequences. Indeed, while H~2~S has been shown to be protective against ischemic injuries \[[@B54], [@B55]\], the enhanced biosynthesis and chemical stability of H~2~S, combined with the reduced content in mitochondria (the main sites of sulfide disposal), may increase the risk of H~2~S toxicity in hypoxic cells.

This information prompted us to investigate in the present study the effect of hypoxia on the mitochondrial sulfide-oxidizing activity and SQR expression in colorectal cancer cells.

2. Materials and Methods {#sec2}
========================

2.1. Materials {#sec2.1}
--------------

The human colon cancer cell line SW480 was purchased from the American Type Culture Collection (ATCC no. CCL228™). Sodium sulfide nonahydrate (Na~2~S·9H~2~O, 431648), 5,5′-dithiobis-(2-nitrobenzoic acid) (DTNB), acetyl coenzyme A, oxaloacetate, CelLytic™ MT cell lysis reagent, protease inhibitor cocktail (P8340), and rabbit polyclonal antibody against human SQR (HPA017079) were purchased from Sigma. The bicinchoninic acid assay (BCA) kit was from Thermo Fisher Scientific. Cell culture media and antibiotics were from Sigma, EuroClone, or Gibco. Mini-PROTEAN TGX Stain-Free Precast Gels, the Clarity Western ECL Substrate, and the Laemmli protein sample buffer were purchased from Bio-Rad. Bovine serum albumin was from AppliChem.

2.2. Preparation of Sulfide Stock Solutions {#sec2.2}
-------------------------------------------

Stock solutions of Na~2~S were prepared by quickly washing the surface of a crystal of sodium sulfide nonahydrate with degassed ultrapure (Milli-Q®) water and then dissolving it in degassed Milli-Q water under N~2~ atmosphere, as reported in \[[@B56]\]. The concentration of Na~2~S in solution was measured spectrophotometrically using 5,5′-dithiobis-(2-nitrobenzoic acid) (DTNB) according to Nashef et al. \[[@B57]\] in a Cary 60 UV-VIS spectrophotometer. The concentration of Na~2~S was then adjusted to 3-5 mM by dilution with degassed ultrapure (Milli-Q®) water in a gas-tight glass syringe.

2.3. Cell Culture {#sec2.3}
-----------------

The human colon cancer cell line SW480 was maintained in Dulbecco\'s Modified Eagle Medium (DMEM) containing 4.5 g·L^−1^ glucose, supplemented with 2 mM [l]{.smallcaps}-glutamine, 10% (*v*/*v*) heat-inactivated fetal bovine serum (FBS), 100 U·mL^−1^ penicillin, and 100 *μ*g·mL^−1^ streptomycin. Cells at 37°C and 5% CO~2~ in 25 cm^2^ or 75 cm^2^ flasks were grown under normoxic conditions (air O~2~) or incubated for 24 h under hypoxic conditions (1% O~2~) in a Galaxy 14 S incubator (Eppendorf) designed to maintain cell cultures at controlled O~2~ tension. After trypsinization, the cells were washed in the culture medium, counted using the trypan blue dye exclusion test, centrifuged at 1000 ×g for 5 min, and resuspended in fresh medium at a final density of 8 × 10^6^ cells·mL^−1^. Trypan blue-positive cells were always less than 5%. Cells grown under air conditions or exposed to hypoxia are, respectively, referred to as "normoxic" and "hypoxia-treated" cells.

2.4. Measurements of the Mitochondrial Sulfide-Oxidizing Activity {#sec2.4}
-----------------------------------------------------------------

The mitochondrial sulfide-oxidizing activity of tested cells was evaluated as described in \[[@B25]\], by measuring the stimulatory effect of sulfide on cellular O~2~ consumption. Measurements were carried out at 37°C, using a high-resolution respirometer (Oxygraph-2k, Oroboros Instruments, Innsbruck, Austria), equipped with two 1.5 mL chambers and a micropump (TIP-2k) allowing for steady injections of relatively small amounts of sulfide into the chambers. According to Abou-Hamdan et al. \[[@B25]\], in these assays, sulfide is injected into a cell suspension at increasing flux (determined by the pump rate) and the mitochondrial sulfide-detoxifying activity is evaluated from the observed stimulation of cellular O~2~ consumption. Indeed, upon increasing the rate of sulfide injection, the concentration of sulfide in solution and, in turn, the sulfide-sustained cellular O~2~ consumption increase until the concentration of injected sulfide becomes inhibitory for CcOX. In colorectal cancer cells, SQR-mediated sulfide detoxification was shown to promote both forward electron transfer to O~2~ via quinol:cytochrome *c* reductase (complex III)/cytochrome *c*/CcOX and reverse electron transfer through complex I \[[@B21]\]. Therefore, measurements were herein carried out in the presence of rotenone, a known inhibitor of complex I, to prevent electrons derived from SQR-mediated sulfide oxidation to be partially diverted from O~2~ reduction with consequent underestimation of the mitochondrial sulfide-oxidizing activity. Herein, the assays were typically conducted in FBS-supplemented cell medium under stirring as follows. A suspension of four million cells was added into the respirometer chamber, and the basal respiration was measured for \~10 min. Afterwards, following the addition of 5 *μ*M rotenone resulting in O~2~ consumption inhibition, a solution of 3-5 mM sulfide was injected for time intervals of 180 s at increasing rates (10 nL·s^−1^, 20 nL·s^−1^, 40 nL·s^−1^, 80 nL·s^−1^, and 160 nL·s^−1^) and the effect on O~2~ consumption was measured. Control experiments were carried out in the presence of both rotenone (5 *μ*M) and antimycin A (5 *μ*M), an inhibitor of complex III. The latter assays allowed us to evaluate the effect of sulfide on extramitochondrial and nonenzymatic O~2~ consumption and thus obtain by subtraction (from the experiments performed in the absence of antimycin A) the genuine mitochondrial O~2~ consumption activity due to sulfide oxidation and from it an estimate of the H~2~S-oxidizing activity, considering that \~1.33 molecules of H~2~S per O~2~ molecule are reportedly consumed by the mitochondrial sulfide-oxidizing pathway \[[@B21]\].

2.5. Evaluation of Mitochondrial Content by the Citrate Synthase Assay {#sec2.5}
----------------------------------------------------------------------

Cells were harvested and lysed using the CelLytic™ MT cell lysis reagent and protease inhibitor cocktail from Sigma according to the manufacturer\'s instructions. Cell extracts were assayed spectrophotometrically for citrate synthase in 100 mM Tris-HCl, 0.3 mM acetyl-CoA, 0.1 mM DTNB and 0.1 mM oxaloacetate, as described in \[[@B58]\].

2.6. Immunoblotting Assays {#sec2.6}
--------------------------

Cells were harvested and lysed as described in the previous section, and after total protein content determination by the bicinchoninic acid method, proteins (20 *μ*g per lane) were separated by SDS-PAGE using Mini-PROTEAN TGX Stain-Free Precast Gels (Bio-Rad). The formulation of these gels includes trihalo compounds which lead to UV fluorescence emission upon reaction with proteins \[[@B59]\], allowing estimation of the total protein load in a gel lane, using a ChemiDoc MP imaging system (Bio-Rad) without resorting to staining procedures or housekeeping proteins for normalization purposes. Proteins commonly used as housekeepers, such as glyceraldehyde 3-phosphate dehydrogenase and *β*-actin, indeed are known to change their expression levels under hypoxia \[[@B60], [@B61]\]. Afterwards, the proteins separated by SDS-PAGE were transferred onto a polyvinylidene difluoride membrane using a Trans-Blot SD Semi-Dry Electrophoretic Transfer Cell (from Bio-Rad) at 180 mA for 30 min. The membrane was blocked with PBS-T (phosphate-buffered saline with 0.1% Tween 20 (*v*/*v*)) containing 3% bovine serum albumin (BSA, *w*/*v*) and then incubated overnight at 4°C with the antibody against human SQR (1 : 150, in PBS-T with 3% BSA (*w*/*v*)). After three washing steps with PBS-T (15 min), the membrane was incubated with horseradish peroxidase-conjugated secondary antibody (1 : 5000, in PBS-T with 3% BSA (*w*/*v*)), followed by three washing steps with PBS-T (15 min) and detection by enhanced chemiluminescence (Clarity Western ECL Substrate, Bio-Rad). Finally, the blotted membrane was subjected to densitometric analysis using the Image Lab software (Bio-Rad), followed by the normalization of the target protein band intensity to the total protein load determined as described above.

2.7. Data Analysis {#sec2.7}
------------------

Oxygen consumption rates (OCR) were calculated using the software DatLab4 (Oroboros Instruments, Austria). Data are reported as mean ± standard error of the mean (SEM). Statistical significance (*P*) was estimated using Student\'s *t*-test in Microsoft Excel. ^∗^*P* ≤ 0.05, ^∗∗^*P* ≤ 0.01, and ^∗∗∗^*P* ≤ 0.001 were considered significant.

3. Results {#sec3}
==========

Colorectal cancer SW480 cells were either grown under normoxic (air O~2~) conditions or exposed for 24 h to hypoxia (1% O~2~), and their sulfide-oxidizing activity was assayed by high-resolution respirometry, according to Abou-Hamdan et al. \[[@B25]\], as described in Materials and Methods. A representative oxygraphic trace acquired with untreated ("normoxic") cells is shown in [Figure 1(a)](#fig1){ref-type="fig"}. The trace shows that \~80% of oxygen consumption was blocked by the addition of the complex I inhibitor rotenone, added to prevent sulfide oxidation through reversal of complex I activity, as described in \[[@B21], [@B62]\]. Sulfide was then injected five times at increasing rates into the oxygraphic chamber via a micropump. The first four injections led to the stimulation of O~2~ consumption, pointing to a fully operative mitochondrial sulfide-oxidizing pathway in the tested cells (Figures [1(a)](#fig1){ref-type="fig"} and [1(b)](#fig1){ref-type="fig"}). The stimulation persisted for the entire duration (3 minutes) of sulfide injection, after which the O~2~ consumption rate (OCR) declined back to the value measured in the absence of sulfide. The decline took a few minutes, as if some sulfide persisted in solution, sustaining cell respiration even after the injection was stopped. The extent of O~2~ consumption stimulation by sulfide increased with the rate of sulfide injection (up to 80 nL·s^−1^, Figures [1(a)](#fig1){ref-type="fig"} and [1(c)](#fig1){ref-type="fig"}). However, upon further increasing the injection rate (to 160 nL·s^−1^), a decline in OCR was observed already before sulfide injection was stopped, likely due to CcOX inhibition by sulfide, as suggested previously \[[@B25]\].

For comparison, the measurements described above were carried out on the same cells after 24 h exposure to hypoxic conditions. A representative oxygraphic trace is shown in [Figure 1(b)](#fig1){ref-type="fig"}. Hypoxia-treated cells displayed a lower basal respiratory activity compared to untreated cells (6.3 ± 0.5 nM O~2~·s^−1^ vs. 17.1 ± 1.1 nM O~2~·s^−1^ per million cells). Yet, as observed for normoxic cells, after rotenone addition a progressive stimulation of cell respiration was observed upon injecting sulfide at an increasing rate (Figures [1(b)](#fig1){ref-type="fig"} and [1(d)](#fig1){ref-type="fig"}), until the amount of injected sulfide exceeded the detoxifying activity of the cells, and CcOX inhibition occurred, leading to impairment of cell respiration (see last sulfide injection in [Figure 1(b)](#fig1){ref-type="fig"}, top).

To evaluate the contribution of mitochondria to the observed sulfide-oxidizing activity, we used antimycin A, a known inhibitor of complex III that blocks quinol oxidation in the respiratory chain and thus prevents sulfide oxidation by mitochondria \[[@B25]\]. As shown in Figures [1(a)](#fig1){ref-type="fig"} and [1(b)](#fig1){ref-type="fig"} (bottom traces), in the presence of rotenone, antimycin A considerably prevented O~2~ consumption stimulation by sulfide in both normoxic and hypoxia-treated cells, proving that under the tested conditions sulfide oxidation occurs mostly at the mitochondrial level. The effect of sulfide on mitochondrial O~2~ consumption was quantitatively evaluated by subtracting the OCR values measured during sulfide injection in the presence of both rotenone and antimycin A from those measured at identical sulfide injection rates in the presence of rotenone only (see legend of [Figure 1](#fig1){ref-type="fig"} for more details). According to this analysis, at the highest non-inhibitory (for CcOX) injection rate sulfide sustained a mitochondrial O~2~ consumption of 9.7 ± 1.2 nM O~2~·s^−1^ and 7.3 ± 0.8 nM O~2~·s^−1^ per million cells, in normoxic and hypoxia-treated cells, respectively. Considering that the mitochondrial sulfide-oxidizing pathway overall was reported to consume \~1.33 molecules of H~2~S per O~2~ molecule \[[@B21]\], a mitochondrial sulfide-oxidizing activity of 12.8 ± 1.5 and 9.7 ± 1.1 nM H~2~S·s^−1^ per million cells was estimated for normoxic and hypoxia-treated cells, respectively ([Figure 2(a)](#fig2){ref-type="fig"}). To evaluate the mitochondrial content in the tested cells, we carried out citrate synthase activity assays, a validated surrogate biomarker of mitochondrial content (\[[@B63]\] and references therein). Normoxic and hypoxia-treated cells displayed, respectively, a citrate synthase activity of 1.1 ± 0.1 *μ*mol·min^−1^·10^6^ cells^−1^ and 0.6 ± 0.1 *μ*mol·min^−1^·10^6^ cells^−1^ ([Figure 2(b)](#fig2){ref-type="fig"}), consistent with a reduction in the mitochondrial content upon exposure to hypoxia \[[@B44]--[@B46]\]. The measured citrate synthase activity was used to normalize the calculated mitochondrial sulfide-oxidizing activity, which proved to be in hypoxia-treated cells \~1.4-fold higher than in normoxic cells ([Figure 2(c)](#fig2){ref-type="fig"}). Finally, we have assayed by immunoblotting combined with "*stain-free*" imaging technology the SQR expression level in the tested cells ([Figure 3(a)](#fig3){ref-type="fig"}) and found that hypoxia-treated cells display 1.4-fold higher SQR protein levels than normoxic cells ([Figure 3(b)](#fig3){ref-type="fig"}). Considering that hypoxia-treated cells have a lower mitochondrial content (based on citrate synthase activity assays, [Figure 2(b)](#fig2){ref-type="fig"}), we estimate that the mitochondria of hypoxia-treated cells contain 2.6-fold more SQR than those of normoxic cells ([Figure 3(c)](#fig3){ref-type="fig"}).

4. Discussion {#sec4}
=============

O~2~ and H~2~S are key molecules in living systems, able to control each other\'s availability, and regulate numerous processes in human (patho)physiology. As reviewed in \[[@B47]\], the interplay between H~2~S and O~2~ is intricate and based on several mechanisms: (i) direct reaction between the two, (ii) O~2~-dependent H~2~S breakdown through the mitochondrial sulfide-oxidizing pathway, (iii) H~2~S-mediated stimulation or inhibition of mitochondrial O~2~ consumption, (iv) O~2~-dependent regulation of expression and cellular relocalization of the H~2~S-synthesizing enzymes, and (v) O~2~-dependent control of CO-mediated inhibition of H~2~S production by CBS. H~2~S has indeed been recognized as an O~2~ sensor \[[@B64]\]. Despite this, to our knowledge no studies have been conducted yet to explore the effect of prolonged exposure to hypoxia on the cell ability to dispose of H~2~S, which represented the main objective of the present study.

Under hypoxic conditions, H~2~S plays a key protective role against ischemia/reperfusion damages \[[@B54], [@B55]\] through only partly understood molecular mechanisms including induction of antioxidant and vasorelaxation effects on microcirculation. Moreover, H~2~S appears to mediate the repair of damaged mitochondrial DNA \[[@B36]\], occurring in ischemia/reperfusion, and to protect from hypoxia-induced proteostasis disruption, as demonstrated in *Caenorhabditis elegans* \[[@B65]\]. In knockdown experiments with Hepa1-6 cells, H~2~S-mediated protection during O~2~ deprivation was found to require SQR \[[@B66]\], pointing to a key role of H~2~S catabolism in the cellular protective responses to hypoxia. Consistently, under hypoxic conditions, thiosulfate, a major product of H~2~S oxidation, has been shown to exert protective effects against ischemia/reperfusion damage \[[@B66]--[@B68]\] and also to generate H~2~S \[[@B69]\]. In this context, it is noteworthy that H~2~S is able to mimic hypoxia-induced responses such as vasodilation \[[@B70]\], neoangiogenesis \[[@B71]\], and expression of the hypoxia-inducible factor (HIF-1*α*, \[[@B72]\]), a master gene regulator promoting cell survival under hypoxic conditions shown to stimulate CBS expression in hypoxia \[[@B49]\]. The occurrence of H~2~S under hypoxic conditions is therefore likely part of a more general adaptive response adopted by the cells to ensure survival and protection from damages resulting from O~2~ deprivation (and possible reoxygenation).

In hypoxic cells, H~2~S bioavailability therefore needs to be finely regulated for this gaseous molecule to occur at physiologically protective yet non-poisonous levels. In this regard, it seems relevant to gain insight into the regulation of H~2~S production and breakdown at low O~2~ tensions. Previous studies focused on the H~2~S-synthesizing enzymes have shown that, under hypoxic conditions, H~2~S synthesis is enhanced \[[@B47]\] through multiple mechanisms \[[@B49]--[@B53]\] (see Introduction). In addition, H~2~S breakdown via both chemical and enzymatic reaction pathways is negatively affected by low O~2~ tensions. Evidence for a lower mitochondrial sulfide-oxidizing activity at lower O~2~ concentrations was initially provided in \[[@B73]\] working on immortalized cells derived from alveolar macrophages and, then, corroborated by Abou-Hamdan et al. in a more recent investigation on CHO cells \[[@B74]\].

In the present study, using SW480 colorectal cancer cells as a model, we tested the effect of prolonged (24 h) exposure to 1% O~2~ on the cellular ability to dispose of sulfide at the mitochondrial level. Exposure to hypoxia leads to a notable (2.7-fold) reduction in basal respiration and to a marked (1.8-fold) decrease in the mitochondrial content ([Figure 2(b)](#fig2){ref-type="fig"}), as previously documented and suggested to result from enhanced mitophagic activity and reduced organelle biogenesis \[[@B44]--[@B46]\]. Hypoxia-treated cells also display a lower ability to dispose of H~2~S as compared to normoxic cells ([Figure 2(a)](#fig2){ref-type="fig"}). However, considering the above-mentioned decrease in mitochondrial content, the sulfide-detoxifying capacity of hypoxia-treated cells normalized to their minor mitochondrial content actually turned out to be 1.4-fold higher than that of untreated cells, pointing to an enhanced sulfide disposal capacity of mitochondria in hypoxia-treated cells. To gain further insight, we analyzed the SQR expression by immunoblotting, employing "*stain-free*" imaging technology for total protein quantitation and normalization purposes. Using this approach, we made the somewhat puzzling observation that hypoxia-treated cells, though displaying slightly reduced overall sulfide-oxidizing activity, have modestly (\~1.4-fold) increased SQR levels. Interestingly, normalizing the SQR expression to the mitochondrial content revealed that, in line with their enhanced sulfide-oxidizing capacity, mitochondria of hypoxia-treated SW480 cells have \~2.6-fold higher levels of SQR than those of normoxic cells. Altogether, these results are intriguing in that they suggest that mitochondria in hypoxia-treated cells display lower mass but are enriched in SQR. The increased SQR levels could have a protective role in hypoxic cells preventing mitochondria to be poisoned by enhanced production of sulfide ([Figure 4](#fig4){ref-type="fig"}).

5. Conclusions {#sec5}
==============

This is to our knowledge the first study in which the effect of prolonged cell exposure to hypoxia on the mitochondrial sulfide-oxidizing activity has been evaluated. The evidence collected here on SW480 colorectal cancer cells shows that hypoxia-treated cells metabolize sulfide with overall reduced maximal efficacy and have reduced mitochondrial content, but mitochondria are better equipped to dispose of H~2~S. Physiologically, this may represent a regulatory mechanism to ensure higher protective H~2~S levels, while protecting mitochondria from H~2~S toxicity.

This work was partially supported by the Ministero dell\'Istruzione, dell\'Universita e della Ricerca of Italy (PNR-CNR Aging Program 2012--2014 and PRIN 20158EB2CM_003 to AG). iNOVA4Health Research Unit (LISBOA-01-0145-FEDER-007344), which is cofunded by Fundação para a Ciência e Tecnologia/Ministério da Ciência e do Ensino Superior, through national funds, and by FEDER under the PT2020 Partnership Agreement, is acknowledged by JBV.

H~2~S:

:   Hydrogen sulfide

SQR:

:   Sulfide:quinone oxidoreductase

NO:

:   Nitric oxide

CO:

:   Carbon monoxide

CcOX:

:   Cytochrome *c* oxidase

CBS:

:   Cystathionine *β*-synthase

CSE:

:   Cystathionine *γ*-lyase

MST:

:   3-Mercaptopyruvate sulfurtransferase

SO~4~^2-^:

:   Sulfate

S~2~O~3~^2-^:

:   Thiosulfate

DTNB:

:   5,5′-Dithiobis-(2-nitrobenzoic acid)

PBS-T:

:   Phosphate-buffered saline with 0.1% Tween 20 (*v*/*v*)

OCR:

:   Oxygen consumption rate.

Data Availability
=================

The data used to support the findings of this study are available from the corresponding authors upon request.

Conflicts of Interest
=====================

The authors declare that there is no conflict of interest regarding the publication of this paper.

![Stimulation of O~2~ consumption by sulfide. Representative oxygen consumption traces (blue) and corresponding O~2~ consumption rate (OCR, red traces) acquired with normoxic (a) or hypoxia-treated SW480 cells (b), following the addition of cells (4 × 10^6^), rotenone (Rot., 5 *μ*M) either alone (top traces) or plus antimycin A (Ant. A, 5 *μ*M, bottom traces), and subsequent injection of a sulfide solution (3-5 mM) at increasing rates (10 nL·s^−1^, 20 nL·s^−1^, 40 nL·s^−1^, 80 nL·s^−1^, and 160 nL·s^−1^, corresponding, respectively, to injections \#1 to \#5). (c, d) OCR values obtained from the oxygraphic traces, respectively shown in (a) and (b), measured at basal condition and upon sulfide injection at increasing rates after addition of rotenone alone (full symbols) or rotenone plus antimycin A (hollow symbols). Mitochondrial H~2~S consumption in normoxic cells was calculated by determining the OCR measured at the highest non-inhibitory H~2~S injection rate (highlighted with grey bar in (c)) and subtracting the OCR measured after the addition of rotenone (horizontal dashed line in (c)), yielding ΔOCR~(-Ant)~. Then, the ΔOCR at the corresponding sulfide injection in the antimycin A-containing measurement was calculated in the same manner, yielding ΔOCR~(+Ant)~. By calculating ΔOCR~(‐Ant)~ − ΔOCR~(+Ant)~, the genuine mitochondrial H~2~S-dependent OCR (OCR~mitH2S~) was determined. Finally, OCR~mitH2S~ was multiplied by 1.33 to account for the number of H~2~S molecules consumed per O~2~ molecule, yielding an estimated sulfide oxidizing activity of 12.7 nM H~2~S·s^−1^·10^6^ cells^−1^. Employing the same procedure for cells exposed to hypoxia (b, d), an activity of 9.5 nM H~2~S·s^−1^·10^6^ cells^−1^ was estimated.](OMCL2019-8102936.001){#fig1}

![Effect of hypoxia on mitochondrial sulfide consumption. (a) Mean values of maximal estimated sulfide consumption activity (calculated as described in the legend of [Figure 1(c)](#fig1){ref-type="fig"}), measured in normoxic (*n* = 9, blue bar) and hypoxia-treated (*n* = 8, red bar) cells. (b) Citrate synthase activity in normoxic (*n* = 13, blue bar) and hypoxia-treated (*n* = 10, red bar) cell lysates. (c) Maximal sulfide consumption activity normalized to the citrate synthase activity, as measured in normoxic (blue bar) and hypoxia-treated (red bar) cells. ^∗^*P* ≤ 0.05; ^∗∗^*P* ≤ 0.01; ^∗∗∗^*P* ≤ 0.001.](OMCL2019-8102936.002){#fig2}

![Effect of hypoxia on SQR expression. Representative Western blot analyzing SQR expression in normoxic and hypoxia-exposed SW480 cells (a), with the corresponding total protein load quantitation by stain-free imaging technology (see Materials and Methods). SQR levels in normoxic (*n* = 4 in triplicate, blue bars) and hypoxia-treated cells (*n* = 4 in triplicate, red bars), as normalized to total protein (b) or citrate synthase activity (c). ^∗∗∗^*P* ≤ 0.001.](OMCL2019-8102936.003){#fig3}

![Adaptive changes occurring in mitochondria in response to hypoxia. Upon prolonged exposure to hypoxia, mitochondria become less abundant, but enriched in sulfide:quinone oxidoreductase (SQR). Consistently, their maximal sulfide-oxidizing activity increases, while overall decreasing in the cell. These changes are proposed to occur to prevent H~2~S inhibition of cytochrome *c* oxidase (CcOX) and thus protect cell respiration from H~2~S poisoning.](OMCL2019-8102936.004){#fig4}
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